Retail Sales Data Indicates Consumer Spending Strength for Third Consecutive Month TJX Companies Analyst Report Highlights Potential for OffPrice Retail Sector Apollo Hospitals Grasim Varun Beverages Among BSE 100 Stocks Hitting 52Week Highs Government to Offload Up to 2 Stake in Coal India via Offer for Sale at Rs 412Share Floor Price Robert Kiyosaki Predicts Gold Could Reach 10000 Silver 200 Amid Inflation and Debt Concerns Amazon Reports Record Thanksgiving Holiday Week Sales and Items Sold AEMD Q1 2026 Earnings NarrowerthanExpected Loss Boosts Investor Sentiment Ecopetrol EC Q4 2025 Earnings EPS Falls Short of Expectations Amid Cost Pressures VersaBank VBNK Q1 2026 Earnings EPS Miss Amid Challenging Quarter Definitive Healthcare DH Q1 2026 Earnings EPS Beats Estimates by Wide Margin Stock Rises Annovis Bio Q1 2026 Earnings EPS Misses Estimates but Shares Rally on Pipeline Optimism BrightSpring Health Services BTSG Holds Near Resistance Signaling Caution BKV Corporation Edges Lower After Recent Rally Tests Key Support Levels Columbus Circle Capital Corp II CMII Holds Steady Near 990 With Minimal Price Movement Western Asset High Yield Opportunity Fund HYI Edges Higher Amid Steady Income Demand SPX Technologies SPXC Edges Higher as Stock Consolidates Near Resistance Chevron Eyes 217 Billion Boost from Asia Pacific Asset Sale SpaceX Successfully Launches Starship Test Flight on Second Attempt Advancing Reusable Rocket Technology Social Security Claiming Dilemma Early Benefits at 62 vs Survivors Option at 67 for LowerIncome Retirees Singapore Stocks Edge Higher as MidEast Tensions Keep Investors Cautious STI Rises 04 ASE Technology and WUS Printed Circuit Forge Strategic Alliance for Advanced Packaging Facility in Taiwan Manufacturing Energy and Carbon Footprints 2018 MECS Department of Energy Report Published Disney Shares Surge 7 as Streaming and Parks Segments Drive Revenue Beat in CEO Josh DAmaros First Earnings Report CSR Q1 2026 Earnings EPS Misses Estimates Sharply Stock Gains on Strategic Outlook Acrivon Therapeutics ACRV Narrows Lower as Biotech Sentiment Remains Cautious